Check out the businesses making headlines in noon buying and selling. eBay – Shares jumped nearly 10% and touched 52-week highs after asserting that Meta is testing utilizing its listings on Facebook Marketplace . Buyers from Facebook might be redirected to eBay to finish transactions. The achieve put the inventory on observe for its finest day since late 2022. Edison International – The inventory misplaced 10.2%, as 1000’s flee the Los Angeles space because of wildfires destroying houses and infrastructure within the area. The decline put the California-based utility on observe for its worst buying and selling day since March 2020. Getty Images – Shares of the picture database plunged 17.6%, reversing course after hovering greater than 24% within the earlier session. On Tuesday, Getty introduced a $3.7 billion merger with Shutterstock . Shutterstock shares tumbled 11.1% on Wednesday after gaining 14.8% within the earlier session. SolarEdge Technologies – Shares moved 14.8% decrease following Citi’s downgrade to promote from impartial. The financial institution mentioned the corporate faces “stubbornly excessive” working bills regardless of restructuring efforts. The inventory superior greater than 6% and about 8% on Monday and Tuesday, respectively, after SolarEdge disclosed in a SEC submitting that it could minimize 400 jobs. Quantum computing shares – Stocks tied to quantum computing fell after Nvidia CEO Jensen Huang mentioned the expertise is probably going a long time away . Shares of Rigetti Computing and D-Wave Quantum shed greater than 45% and 36%, respectively, whereas Quantum Computing dropped greater than 43%. IonQ slid 39%. Maplebear – The grocery supply firm, which does enterprise as Instacart, jumped greater than 4% forward of its inclusion within the S & P MidCap 400 index , efficient earlier than the bell on Jan. 14. Maplebear is ready to exchange Enovis within the index. AAR Corp – Shares of the aviation providers supplier gained greater than 8% on the again of an earnings and income beat for its fiscal second quarter. For the interval, AAR posted adjusted earnings of 90 cents per share on income of $686.1 million. Analysts polled by FactSet have been anticipating 85 cents per share and $654.2 million in income. Palantir Technologies – Shares shed 2.5%, constructing on their early 2025 droop. The inventory kicked off the week by falling about 5% after Morgan Stanley assumed protection with an underweight score , pointing to a risk-reward profile that is skewed to the draw back. Also earlier this week, Cathie Wood bought greater than $15 million value of the software program firm’s shares throughout all of her Ark funds. Week thus far, the inventory has fallen round 15%. Arcadium Lithium – Shares jumped greater than 8% after the corporate mentioned it acquired clearance from the Committee on Foreign Investment within the United States (CFIUS) for its proposed acquisition by Rio Tinto . Arcadium Lithium expects the transaction to shut earlier than mid-2025. Boston Scientific – The inventory gained 4.3% on the heels of its announcement that it is agreed to amass Bolt Medical . Boston Scientific mentioned it expects the deal to be accomplished within the first half of this 12 months. Advanced Micro Devices – The inventory misplaced 4.3% after receiving a downgrade to scale back from purchase at HSBC, which mentioned that the chipmaker’s AI roadmap is much less aggressive than beforehand thought. Cal-Maine Foods – The egg producer rose 1% following its newest quarterly outcomes . Cal-Maine Foods earned $4.47 per share and $954.7 million in income, with the latter determine marking an 82% enhance from the identical interval a 12 months in the past. Shell – The vitality large fell 1.8% after it trimmed its fourth-quarter liquified pure gasoline manufacturing outlook and mentioned that it expects its oil and gasoline buying and selling outcomes to return in “considerably decrease” than within the third quarter. Novo Nordisk – Shares popped practically 3% after UBS upgraded the pharmaceutical large to a purchase score from impartial. “Novo stays essentially the most thrilling progress story in European pharma and is effectively positioned to proceed to profit from the excessive demand for GLP-1 drugs near-term,” the financial institution wrote. Shares of Novo Nordisk plunged 40% over the previous six months and ended 2024 with a 17% decline. Accolade – The inventory surged nearly 105% following the announcement that the corporate is being acquired by Transcarent for $7.03 per share in money, representing a complete fairness worth of round $621 million. The deal is anticipated to shut in the course of the second quarter of 2025. — CNBC’s Fred Imbert, Alex Harring, Samantha Subin and Lisa Kailai Han contributed reporting.
